Study of response to naproxen in patients with hepatocellular carcinoma who developed fever following transcatheter arterial embolization.
Good antipyretic response was obtained when naproxen was given at 600 mg/day for about one week to patients who developed fever after transcatheter arterial embolization (TAE). Fever recurred in several patients, but subsided again when naproxen was given at 300 mg/day. No patients developed gastric mucosal lesions of clinical concern that seemed to be related to naproxen.
Akaji
H
H
Department of Internal Medicine, Nishiyodo Hospital, Japan.
Hagino
M
M
Inoue
K
K
Hirota
N
N
Nakamura
H
H
D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000009:adverse effects*; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D009288:Naproxen / Q000627:therapeutic use*
D009288:Naproxen